Demand for cheaper Ozempic options prompts compounding rule review
Read the full story on BizcommunitySouth Africa is revising its rules on customising medicines, including sought-after GLP-1 treatments for diabetes and weight loss, health regulators said, warning pharmacies not to act as small-scale manufacturers.
This story was written and published by Bizcommunity. Business.co.za shows its headline and teaser from the publisher’s RSS feed and links to the original.